International Post-Marketing Surveillance of Willfact-Wilfactin in Patients With Inherited Von Willebrand Disease.
Phase of Trial: Phase IV
Latest Information Update: 17 Aug 2018
Price : $35 *
At a glance
- Drugs Von Willebrand factor (Primary)
- Indications Von Willebrand disease
- Focus Therapeutic Use
- Acronyms WINGS
- Sponsors LFB
- 07 Aug 2018 Status changed from recruiting to completed.
- 23 Aug 2017 Planned End Date changed from 1 Jun 2017 to 1 Oct 2017.
- 23 Aug 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Oct 2017.